Regenerative Biologics Supplier for Orthopedic Practices in Spokane, WA

How a Spokane orthopedic practice typically qualifies a vendor

Most orthopedic practices and surgery centers route a new tissue or biologics vendor through whoever already owns implant and supply purchasing: a practice administrator, materials manager, or an ASC's clinical director. That person usually wants three things before a product is added to formulary: a certificate of analysis for the specific lot, a donor eligibility summary, and confirmation that the supplier's registration and licensure documentation is available to review.

Precision Biologics builds its account process around that sequence rather than around a sales conversation. A verified account can request lot-specific paperwork before committing to an order, and nothing ships to an unverified NPI.

Receiving cold-chain shipments in the West region

Cryopreserved Wharton's jelly products ship overnight on dry ice in validated containers and are stored at -80 degrees C prior to shipment. For a practice in Spokane, that means building a receiving process around a defined delivery window: someone on staff confirming the package, checking that dry ice is still present, and logging the lot number into inventory immediately rather than leaving it at a front desk.

Because every product is tracked by lot through to the patient record, a consistent intake step at receiving is what keeps that traceability intact once the product is inside the practice.

Confirming regulatory posture before ordering

Whether a specific intended use fits within the 361 HCT/P framework, or how an exosome product should be classified and handled under section 351, is a determination for the practice and its own counsel; Precision Biologics does not make that call for a customer. Practices in Washington should confirm their own position with the Washington medical board and legal counsel before adding either product category to a formulary.

We supply the certificate of analysis, donor eligibility summary, and lot release record so that review can happen with real documentation rather than marketing claims.

Setting up a verified account

Account verification requires an NPI number tied to the ordering physician or practice. Once verified, a practice can request physician-level conversations about product documentation, not clinical guidance, and can view pricing, which is not published publicly and is available only to verified accounts.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.